BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yue ZH, Xia CS, Wang H. Performance evaluation of the mindray anti-HCV assay for the detection of hepatitis C virus infection. J Clin Lab Anal 2018;32:e22600. [PMID: 30058207 DOI: 10.1002/jcla.22600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Pan H, Gao Q, Lv P, Xu X, Zhao Z. The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations. Sci Rep 2021;11:8689. [PMID: 33888806 DOI: 10.1038/s41598-021-88138-2] [Reference Citation Analysis]
2 Yue ZH, Xia CS, Wang H. Performance evaluation of the mindray anti-HCV assay for the detection of hepatitis C virus infection. J Clin Lab Anal 2018;32:e22600. [PMID: 30058207 DOI: 10.1002/jcla.22600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Yang S, Yang R, Zhang S, Liu D, Zhou J, Wang T, Cui L. Clinical diagnostic performance of light-initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody. J Clin Lab Anal 2019;33:e22928. [PMID: 31148296 DOI: 10.1002/jcla.22928] [Cited by in F6Publishing: 2] [Reference Citation Analysis]